Pioneering cloud-based framework, hosted by Quantix in
partnership with IDBS, is selected to drive collaboration within
the health science arena to improve patient results.
The UK's national innovation agency, the Technology Strategy
Board, has selected a consortium, which includes Quantix as its
Oracle hosting and Managed
Services provider, to deliver a cloud-based Oracle platform to
support medicine research and cross-organisational collaboration.
The consortium is led by independent software vendor IDBS and also
includes leading cancer centers at Kings Health Partners and
Manchester Academic Health Science Center.
Quantix already has a close partnership with IDBS
through several different projects, delivering a
fully managed hosting solution which enables software as a
service delivery of IDBS applications to their clients. The
partnership allows a powerful combination of skills to be offered
to IDBS' broad R&D and Healthcare customer base and, as
healthcare costs grow, interest in collaborative efforts to support
stratified medicines as a means to deliver safe and cost-effective
treatments increase.
Alongside cost benefits, the cloud-based
platform provides multi-site delivery, securely integrated into
other IT systems, huge capacity for data storage which offers
on-demand scalability and inherent high availability with built in
resiliency and backup. In addition, Quantix bring their experience
of provisioning complex applications via a SaaS delivery model,
extensive expertise of Oracle software and proven database and
application solutions, which, coupled with IDBS's pioneering
application environments, is a unique
cloud hosting offering. The platform provides the
infrastructure for multiple organisations within the health science
industry to support secure stratified medical research and
collaboration including data handling, storage, retrieval and
analysis services which will gather and integrate data from a wide
variety of different organisations and sources.
This project will allow leading cancer centers across the UK to
identify patient populations and develop better understanding of
genetic drivers for cancer, to improve cancer care and more
effective drugs and diagnostics. In addition to the benefits to
patients, it provides unprecedented collaboration between
organisations throughout medical research and industry, leading the
UK's research activities to the next level.
"Quantix is extremely proud to be a part of such a
significant project - not only does it highlight the benefits of
our cloud computing solutions, our expertise with Oracle software,
and the strength of the application hosting platform we have
developed, but it also demonstrates the wider advantages to UK
industry and the medical research communities which our platform,
and cloud-based platforms can offer." said Simon Goodenough,
Sales & Marketing Director of Quantix.